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AbstrAct
The aim of this pilot investigation was to determine if 
microRNA expression differed in the presence or 
absence of obesity, comparing gingival biopsies 
obtained from patients with or without periodontal 
disease. Total RNA was extracted from gingival 
biopsy samples collected from 20 patients: 10 non-
obese patients (BMI < 30 kg/m2) and 10 obese 
patients (BMI > 30 kg/m2), each group with 5 peri-
odontally healthy sites and 5 chronic periodontitis 
sites. MicroRNA expression patterns were assessed 
with a quantitative microRNA PCR array to survey 
88 candidate microRNA species. Four microRNA 
databases were used to identify potential relevant 
mRNA target genes of differentially expressed 
microRNAs. Two microRNA species (miR-18a, miR-
30e) were up-regulated among obese individuals with 
a healthy periodontium. Two microRNA species 
(miR-30e, miR-106b) were up-regulated in non-
obese individuals with periodontal disease. In the 
presence of periodontal disease and obesity, 9 of 11 
listed microRNAs were significantly up-regulated 
(miR-15a, miR-18a, miR-22, miR-30d, miR-30e, miR-
103, miR-106b, miR-130a, miR-142-3p, miR-185, 
and miR-210). Predicted targets include 69 different 
mRNAs from genes that comprise cytokines, chemo-
kines, specific collagens, and regulators of glucose 
and lipid metabolism. The expression of specific 
microRNA species in obesity, which could also target 
and post-transcriptionally modulate cytokine mRNA, 
provides new insight into possible mechanisms of 
how risk factors might modify periodontal inflamma-
tion and may represent novel therapeutic targets.
KEY WOrDs: microRNA, obesity, periodontitis, 
inflammation, epigenetics, PCR-array.
IntrODuctIOn
specific genetic polymorphisms have been associated with a susceptibility to gain weight (Adair and Prentice, 2004). Expression of these susceptibility 
genes can be influenced by epigenetic and environmental factors (Emilsson et al., 
2008). Transcription factors and microRNAs (miRNAs) are abundant regulatory 
systems that are modified by nutritional status. Evidence from in vitro studies 
and, more recently, from human studies has identified specific miRNAs that are 
associated with obesity. miRNAs are small, non-coding RNA molecules that bind 
and form complexes with mRNA species, usually to the 3′UTR of the mRNA. 
miRNA binding to mRNA, even with only moderate strand complementarity, 
serves to repress mRNA translation or can result in mRNA degradation. This lack 
of stringency can result in one miRNA affecting the translation of many different 
target genes. Thus, miRNA expression is a common translational feedback control 
mechanism that has been shown to modulate lipid and carbohydrate metabolism, 
as well as inflammatory pathways (Emilsson et al., 2008; Iliopoulos et al., 2008). 
It is possible that miRNAs that are induced by chronic nutritional stress leading 
to obesity may also non-parsimoniously modulate inflammatory pathways within 
periodontal tissues and affect disease expression.
The role of miRNAs in regulating adipocyte development and lipid 
metabolism has been well-established. Expression of miR-27 suppresses the 
translation of 2 very important early regulators of adipogenesis, namely, per-
oxisome proliferator-activated receptor-γ (PPARγ) and CCAAT/enhancer 
binding protein α (Lin et al., 2009). miR-143 expression is up-regulated 3.3-
fold in obese mice, with similar increases in adipocyte differentiation markers 
PPARγ and adipocyte fatty-acid-binding protein (Takanabe et al., 2008). miR-
122 was determined to be an important regulator of cholesterol and fatty-acid 
metabolism (Esau et al., 2006). miRNA expression in human adipose tissue 
was first studied by Klöting et al. (2009), and significant correlations were 
found between expression of miRNA-17-5p, -132, -99a, -134, 181a, -145, and 
-197 and adipose tissue morphology, metabolic parameters (i.e., HbA1c, fast-
ing plasma glucose) leptin, adiponectin, and interleukin (IL)-6 levels. More 
recently, Martinelli et al. (2010) demonstrated that miR-519d was up- 
regulated in an obese population, and its predicted target was PPARα.
Obesity is an established risk factor for periodontitis (Saito et al., 2001, 
2005; Al-Zahrani et al., 2003; Wood et al., 2003; Lundin et al., 2004; Dalla 
Vecchia et al., 2005; Genco et al., 2005; Nishida et al., 2005), but our under-
standing of how obesity modifies periodontal disease pathogenesis at the 
molecular level is unknown. Recently, some of these miRNA species have 
also been identified as possible modifiers of inflammatory pathways (Emilsson 
et al., 2008; Iliopoulos et al., 2008). For example, inhibition of miR-22 
caused up-regulation of PPARα and bone morphogenetic protein 7 (BMP7), 
blocked the inflammatory process through inhibition of IL-1B, and promoted 
repair in osteoarthritic chondrocytes (Iliopoulos et al., 2008).
MicrornA Modulation in Obesity 
and Periodontitis
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Currently, there are no human data to indicate whether 
miRNA species are differentially expressed in periodontally 
diseased tissues or whether obesity can modify miRNA expression. 
The overall goal of this study was to conduct a pilot investigation 
to determine whether obesity or periodontal disease modified 
miRNA expression, and whether there was any potential interac-
tion between obesity and periodontitis that could involve miRNA 
modulation. We hypothesized that obesity may alter miRNA 
patterns and that some of these miRNA species would also be 
associated with inflammatory gene targets such as PPARγ, nuclear 
factor kappa-B (NFκB), and IL-6.
MAtErIAls & MEthODs
study Participant selection and Gingival tissue biopsies
This study was approved by the Institutional Review Board at 
the University of North Carolina at Chapel Hill. Twenty-four 
participants, aged 18 to 65 yrs, provided informed consent and 
were consecutively recruited from the clinics at the University 
of North Carolina School of Dentistry from May 2010 to 
January 2011. Demographic information and a thorough medi-
cal history questionnaire were obtained for all recruited indi-
viduals. Potential participants were excluded: if they had a 
chronic disease which could present with oral manifestations; if 
they had been treated with antibiotics for any medical or dental 
condition within 1 mo prior to the screening examination; if they 
were being chronically treated (i.e., 2 wks or more) with any 
medication known to affect periodontal status (e.g., phenytoin, 
calcium antagonists, cyclosporin, coumadin, non-steroidal anti-
inflammatory drugs, aspirin > 81 mg) within 1 mo of the screen-
ing examination; if they had clinically significant organ disease, 
including impaired renal function, or any bleeding disorder; and 
if they had active infectious diseases such as hepatitis, HIV, or 
tuberculosis. Experienced study personnel recorded all recruited 
individuals’ height and weight as measured with a precision 
stadiometer and a regularly calibrated digital scale, to compute 
Body Mass Index (BMI). Comprehensive periodontal examina-
tions were performed on all participants by one of two calibrated 
examiners, and probing depths (PDs), clinical attachment level, 
and bleeding on probing (BOP) were recorded at 6 sites per 
tooth. Based on this information, a periodontal diagnosis was 
made according to the currently accepted American Academy of 
Periodontology 1999 Classification System of Periodontal 
Diseases and Conditions (Armitage, 1999). Potential partici-
pants were excluded if they had any acute or chronic diseases 
which resulted in oral manifestations or if they were taking 
medications known to affect the periodontium. Participants 
were enrolled into four groups (six/group) based on BMI (non-
obese BMI < 30 kg/m2 and obese BMI > 30 kg/m2) and the 
presence or absence of chronic periodontitis.
A single biopsy was taken from each participant. For healthy 
individuals, a gingival biopsy sample (including gingival epithe-
lium, the col area, and the underlying connective tissue) was 
collected at the time of a scheduled crown-lengthening proce-
dure. The biopsy site selected in healthy participants was at the 
site of a planned crown-lengthening procedure with healthy 
interproximal papillae. All healthy sites had a probing depth 
≤ 4 mm, no bleeding on probing (BOP), and no evidence of 
radiographic bone loss. A scalpel blade was used to obtain a 
biopsy with intrasulcular and inverse bevel incisions. The inci-
sion extended from the mid-palatal area of 2 adjacent teeth, 
beginning and ending intrasulcularly and going to the bone 
undermining the interproximal papillae, staying approximately 
1 mm from the free gingival margin at the crest of the inter-
proximal papillae and horizontally capturing the interproximal 
col area. For participants with chronic periodontitis, a gingival 
biopsy sample was obtained at the time of a scheduled periodon-
tal flap procedure. A scalpel blade was used to obtain the sample 
from a severely inflamed interproximal periodontitis site, 
defined as a probing depth > 5 mm, and presence of BOP with 
evidence of radiographic bone loss. Gingival biopsy samples 
were immediately placed in RNAlater® (Applied Biosystems/
Ambion Inc., Austin, TX, USA) overnight at 4°C, decanted, and 
stored at −80ºC. Once collected chair-side, samples were placed 
in a cryovial that contained a bar-code label that was totally de-
identified for laboratory processing, but facilitated tracking and 
linking to patient clinical information at the end of the labora-
tory processing for statistical analysis.
rnA Isolation and qrt-Pcr
The study was conducted in a single masked manner such that 
all laboratory assessments were performed without knowledge 
of the participants’ BMI or periodontal status. Total RNA, 
including small RNAs, was isolated from gingival tissue sam-
ples with a TissueLyser LT and miRNeasy Mini Kit (Qiagen, 
Valencia, CA, USA). RNA was quantified by means of a 
NanoDrop ND-1000 spectrophotometer (Thermo Scientific, 
Wilmington, DE, USA), and quality and purity were assessed 
with the 2100 Bioanalyzer (Agilent, Foster City, CA, USA). 
Twenty samples (5/group based on BMI and periodontal status) 
were used for further analysis. Briefly, a volume of 600 ng total 
RNA was used for reverse-transcription reactions to generate 
complementary DNA (cDNA) with the RT2 miRNA First Strand 
Kit (Qiagen, Frederick, MD, USA) according to the manufac-
turer’s instructions. Quantitative real-time PCR (qRT-PCR) was 
performed with 100 μL of cDNA, according to the manufactur-
er’s instructions (Qiagen), in a 7500 Sequence Detection System 
(ABI Prism, Applied Biosystems, Carlsbad, CA, USA). miRNA 
expression patterns were assessed with a human genome RT2 
miRNA PCR Array (SABiosciences) that contained probes for 
88 of the most abundantly expressed and best-characterized 
miRNA sequences in the human miRNA genome. SNORD48 
(Accession Number: NR_002745) and RNU6-2 (Accession 
Number: NR_002752) were used for normalization. 
Amplification parameters, conditions, and melting curves were 
set by the manufacturer. Data were analyzed by the 2−ΔΔCT 
method (Livak and Schmittgen, 2001), and results were reported 
as fold change in miRNA level. with a P-value < 0.05 consid-
ered significant. An ANOVA was used for overall group-effect 
significance and non-paired Student’s t test for comparisons 
between groups without adjustment for multiple comparisons.
bioinformatic mirnA Analysis and target selection
Predicted targets were selected for each of the statistically sig-
nificant differentially expressed human miRNAs if they were 
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identified in either 2 or 3 out of 4 publically available miRNA 
databases, each of which uses different hybridization algorithms 
(see Appendix Table 1). Gene ontology (GO) terms associated 
with inflammation and collagen, glucose, and lipid metabolism 
were used to select target genes of interest.
rEsults
study Population Demographics
The participants’ mean age was 45 yrs (± 13.3 SD), with no 
significant differences among the four groups in age, gender, 
and race (Appendix Table 2). Sixty percent of study participants 
were categorized as never-smokers, and 35% were ex-smokers. 
None of the participants had diabetes. Participants were not 
matched according to age, gender, or race. The non-obese par-
ticipants had a mean BMI of 25.1 kg/m2 (± 2.5 SD), and the 
mean BMI of the obese groups was 35.3 kg/m2 (± 4.5 SD).
Differential mirnA Expression by bMI among 
Participants with Periodontitis
A comparison between participants with a healthy periodontium 
(and non-obese) and participants with periodontitis (either non-
obese or obese) indicated that there was an up-regulation of 10 
miRNAs (P < 0.05) (Fig. 1). Generally, the fold regulation var-
ied from 1.5-fold to 6.4-fold. The majority of miRNA expressed 
in the periodontitis group reached statistical significance in 
those who were also obese. miR-30e was up-regulated in both 
groups, but it was statistically significant only in the periodonti-
tis non-obese group. miR-106b reached a high level of statistical 
significance (P < 0.01) in the periodontitis participants regard-
less of their BMI classification, suggesting a significant role in 
periodontitis pathogenesis. Nevertheless, the fold regulation 
was greater (6.4-fold) for the participants who were obese com-
pared with the non-obese participants (4.9-fold), consistent with an 
enhanced expression of several miRNA species in periodontitis 
table 1. Fold Difference in Expression of microRNA in Biopsy Samples by Obesity and Periodontal Status as Compared with Healthy Non-obese 
Biopsies and BMI Status
BMI Periodontal Status Non-obese Periodontitis Obese Periodontitis Obese Healthy
MicroRNA  
miR-15a 1.6 2.7 1.8
miR-18a 1.3 1.5 1.5
miR-22 3.4 3.1 2.8
miR-30d 2.7 2.2 1.3
miR-30e 4.4 4.9 2.1
miR-103 1.0 1.5 1.2
miR-106b 4.9 6.4** 2.5
miR-130a 5.3 4.6 2.3
miR-142-3p 2.4 5.3** 1.9
miR-185 2.3 3.6 1.2
miR-210 1.4 2.3 1.2
†The referent group includes non-obese participants with a healthy periodontium. Highlighted values: P < 0.05, **P ≤ 0.01.
table 2. microRNAs Associated with GO Term Categories‡
Immunity & Inflammation Collagen Metabolism Lipid Metabolism Carbohydrate Metabolism
miR-15a X X  
miR-18a X X  
miR-22 X X X
miR-30d X X X
miR-30e X X X X
miR-103 X X X
miR-106b X X  
miR-130a X X X X
miR-142-3p X X X
miR-185 X X  
miR-210 X  
‡More detail is provided in Appendix Table 2.
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when obesity is present. In the presence of periodontitis or obe-
sity, there was no significant down-regulation among the 
remaining 78 miRNA species surveyed. The effects of age, race, 
and gender were examined post hoc and were not found to be 
significant.
Differential mirnA Expression in  
Periodontitis among Obese Participants
Similarly, with a non-obese, periodontally healthy referent 
group, a comparison was made among obese individuals 
between those with or without periodontitis (Fig. 2). In peri-
odontally healthy obese individuals, only 2 miRNA species 
(miR-18a, miR-30e) were significantly elevated. Although 
increased in both periodontal health and disease, miR-106b 
expression among obese individuals attained statistical signifi-
cance only among those with periodontitis. Overall, 11 miRNAs 
were identified with significant up-regulation in this study 
cohort (Table 1). Nine of these were up-regulated and reached 
statistical significance only in periodontally diseased individu-
als who were obese. This suggests a role for miRNA in the 
interaction between obesity and periodontal inflammation.
Predicted mrnA targets
To understand the potential modulatory role of these 11 up-
regulated miRNA species associated with obesity and/or peri-
odontal disease, we determined potential mRNA targets linked 
to immunology, inflammation, and metabolic disorders (as 
identified by GO Biological Process Terms) using 4 available 
miRNA databases. Sixty-nine different genes with miRNA tar-
get sequences were identified in 3 out of the 4 databases for the 
11 miRNA species (Appendix Table 2A). When the targets vali-
dated in 2 out of 4 databases were included, 139 different genes 
were identified (listed below in brackets; Appendix Table 2B). 
The potential targets include key cytokines involved in systemic 
inflammation (Appendix Table 2): members of the interleukin 
family (IL1A, IL1F9, IL31 [IL15, IL17B, IL1F8, IL20]) and 
receptors (IL13RA1, IL27RA [IL9R, IL10RB, IL1RL1, 
IL21R]), interferon family (IFNA16, IFNA21 [IFNA1, IFNA2, 
IFNK]) and receptors (IFNAR2, IRF2, IRF5), tumor necrosis 
factor superfamily (TNF, TNFAIP3, TNFSF8, TNFSF14 
[TNFSF9]) and receptors (TNFRSF10A, TNFRSF10D, 
TNFRSF13B [TNFRSF13C]), and a suppressor of cytokine 
signaling (SOCS1); chemokines [CCL1, CCL5, CCL19]; pro-
teins involved in collagen formation and fibroblast growth fac-
tor (COL9A3, COL13A, COL13A1, FGF21); receptor molecules 
involved in metabolism (IRS1, PEX3, PEX13, PPARG, 
PPARGC1B [PPARD, LRP1B, LRP2, LRP6, LRP8, VLDLR]); 
adhesion molecule (ICAM4); and proteases or molecules asso-
ciated with bone metabolism (BAMBI, CASP6, MMP21 
[MMP3, MMP10, MMP13, MMP16, OSTF1]).
DIscussIOn
The data are consistent with the concept that miRNAs induced 
by chronic nutritional stress leading to obesity may also 
non-parsimoniously modulate inflammatory pathways within 
periodontal tissues and affect disease expression. It is well-
established that obesity leads to numerous morbidities such as 
cardiovascular and cerebrovascular disease and is associated 
with increased mortality from cardiovascular events and malig-
nancies. As an impetus to discovering new therapeutic targets 
for adipogenesis, new discoveries have been made regarding 
certain miRNAs and their central role in adipocyte differentia-
tion, metabolic functions, and insulin resistance (Heneghanet 
al., 2010). Recently, Nahid and colleagues (Nahid et al., 2011) 
have reported increased miR-146a expression in an experimen-
tal polymicrobial periodontitis model in mice, but no human 
reports exist. Therefore, the effect of miRNA transcriptional 
repression or mRNA cleavage on periodontal pathogenesis, 
Figure 1. Fold regulation of miRNA species observed in periodontitis 
according to BMI status. Both obese and non-obese periodontitis 
groups were compared with the referent group (healthy periodontium, 
non-obese). miRNA species are listed if at least 1 of the pairwise 
comparisons was significant.
Figure 2. Fold regulation of miRNA species observed in obese 
participants according to periodontal status compared with the 
referent non-obese participants (healthy periodontium). miRNA species 
are listed if at least 1 of the pairwise comparisons was significant.
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especially in the presence of obesity, is largely unknown. In this 
report, we provide the first human data implicating the role of 
miRNA as a potential mechanistic link between obesity and 
periodontal disease pathogenesis.
It is interesting to note that those differentially expressed 
miRNA species exhibited predicted targets that related pre-
dominantly to GO terms associated with key common and con-
vergent molecular pathways (Table 2). These include 
inflammatory cytokines, immune regulation, bone, lipid, and 
glucose metabolism. This suggests that the metabolic influence 
of obesity, which increases the expression of specific miRNAs 
known to regulate lipid and glucose metabolism, also has 
mRNA targets that potentially modulate inflammation and con-
nective tissue metabolism. For example, we found an up-regula-
tion of miR-30e in the obese periodontally healthy patient 
group. Klöting et al. (2009) reported an increased expression of 
miR-30e in subcutaneous adipose tissue and suggested its 
potential involvement in the association between adipose tissue 
dysfunction and the development of obesity-related disorders 
like non-insulin-dependent diabetes mellitus. In this investiga-
tion, higher levels of miR-30e were also seen in the non-obese 
and periodontally diseased subset of patients, suggesting that 
inflammation also up-regulated this miRNA species. While 
none of the study participants had diabetes, a predicted target for 
miR-30e was IRS1, an insulin receptor that, when suppressed, is 
associated with insulin resistance and hyperglycemia. Thus, 
inflammatory-induced miRNA may potentially modulate local 
tissue metabolism.
Up-regulation of miR-103 was observed in participants with 
periodontal disease and an obese BMI. An up-regulation of 
miR-103 (Xie et al., 2009) and miR-143 (Esau et al., 2004; 
Kajimoto et al., 2006) was observed during adipogenesis. We 
demonstrate that predicted targets for miR-103 include members 
of complement-related genes [C1QB, C1QL3], growth factors 
[FGF12, FGFR2, FIGF], interferon [IFNK], interleukins [IL1F8, 
IL20], and insulin-like peptide INSL5.
In a similar, but more comprehensive investigation, Iliopoulos 
and colleagues (2008) demonstrated an interesting association 
between arthritis and BMI. Human osteoarthritic cartilage was 
obtained and compared with normal cartilage. Among the most 
important differences, specific miRNAs (miR-22, miR-103) and 
proteins (PPARA, BMP7, IL1B) were highly correlated with 
BMI. Our study also found a significant up-regulation in miR-
22 expression in the obese and periodontally diseased group 
compared with healthy/non-obese control individuals. The bio-
informatic analysis used in this investigation did not reveal the 
identical predicted targets reported by Iliopoulos and colleagues. 
However, we identified several mRNA targets related to meta-
bolic pathways (APOA5, IGFBP4) and inflammation (IL13RA1, 
IL1F9, IL27RA, IL31, IRF5, TNFRSF10D, TNFRSF13B) 
(Appendix Table 2).
Limitations of this study include the small sample size and 
the survey miRNA qPCR design that targeted only selected 
miRNA species. For example, although many were elevated 
(e.g., miR-18a and miR-30e), no different miRNAs were found 
to achieve statistical significance in non-obese, periodontally 
diseased individuals, reflecting a probable type 2 error. Obesity 
appeared to further increase the expression of these miRNA spe-
cies to achieve statistical significance. Clearly, additional stud-
ies with larger numbers of individuals will be needed to 
adequately assess the role of miRNA in regulating periodontal 
pathogenesis and the impact of obesity as a modifier. The 
increased expression of miR-106b was shared, with the peri-
odontally diseased and obese group showing the largest up-
regulation (6.4-fold). miR-106b is related to carcinogenesis and 
cell-cycle regulation (Ivanovska et al., 2008; Li et al., 2009). In 
this report, we demonstrate that miR-106b in silico predicted 
targets include genes related to inflammation and bone metabo-
lism pathways, such as prostaglandin E2 receptor (PTGER3) and 
tumor necrosis factor superfamily members (TNFSF14, 
TNFRSF10A) (Appendix Table 2). PGE2 and TNF are estab-
lished markers of gingival inflammation within gingival cre-
vicular fluid (Andriankaja et al., 2009). It is important to 
emphasize that these in silico target findings reflect theoretical 
targets calculated from sequence complementarity and second-
ary structure predictions. These hypothetical targets will require 
confirmation by functional assays, such as the use of a luciferase 
reporter construct to assess, for instance, 3′UTR mRNA target-
ing PGE2 or TNF. Further confirmation would require in vitro 
over-expression, knockdown studies, and knockout mice to 
validate these findings.
In conclusion, this investigation demonstrates that the co-
morbidities of obesity and periodontitis are associated with 
significant local up-regulation of several miRNA species that 
share inflammatory and metabolic mRNA targets. The general-
izability of these conclusions is dampened by the small sample 
size, the limited number of survey miRNA species, and the 
non-correction for multiple comparisons in the analyses. However, 
the consistency of the trends and specificity of the response pro-
vide further support for the findings. This is a proof-of-concept 
report, and larger studies will be needed to further validate these 
findings. It is enticing, however, that miRNAs identified in this 
study may play a crucial role in linking the underlying molecu-
lar pathways between obesity and periodontal inflammation. 
Furthermore, these miRNA species may represent novel thera-
peutic targets to manage periodontal disease.
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